2018M&A Transaction Multiples
Pharmacy Multiples - 2018
Sourced from 13 publicly disclosed Pharmacy acquisitions in 2018. Public records only (SEC EDGAR + verified press releases).
EV / EBITDA
11.6x
median · p25 9.1x - p75 20.7x · n=3
EV / Revenue
0.8x
median · p25 0.3x - p75 2.1x · n=12
Value your Pharmacy business
Instant valuation range + a sellability score with the 5 specific drivers worth the most at the LOI table. Backed by 25,592 real M&A transactions.
Pharmacy multiples by year
Other verticals - 2018 multiples
Advertising Agency· 18.42x EBITDAAerospace· 11.52x EBITDAApparel· 8.71x EBITDAConsumer Products· 9.75x EBITDAElectronics· 16.41x EBITDAFood Manufacturing· 15.3x EBITDAGaming· 9x EBITDAHealthcare IT· 16.4x EBITDAHome Health· 6.1x EBITDAIndustrial Equipment· 9.93x EBITDAIT Services· 9.41x EBITDALaboratory Services· 16.9x EBITDAMedical Devices· 15.7x EBITDAMedical Practice Specialty· 11.21x EBITDAMental Health· 9.95x EBITDAMetal Fabrication· 7.06x EBITDAOil Gas Services· 10.66x EBITDAOther· 14.1x EBITDAOther Healthcare· 10.1x EBITDAOther Manufacturing· 9.32x EBITDAOther Personal Services· 8.03x EBITDAOther Professional Services· 10.48x EBITDAOther Technology· 14.06x EBITDAPackaging· 10.34x EBITDA
Data sourced from 13 disclosed Pharmacy M&A transactions in 2018. Aggregations: median (p50), p25, p75. Quality gate: n ≥ 10 deals per (vertical x year) cell. Data generated 2026-05-26.Full methodology →